학술논문
Endocrine-Sensitive Disease Rate in Postmenopausal Patients with Estrogen Receptor-Rich/ERBB2-Negative Breast Cancer Receiving Neoadjuvant Anastrozole, Fulvestrant, or Their Combination: A Phase 3 Randomized Clinical Trial
Document Type
Article
Author
Ma, C.X.; Vij, K.; Hoog, J.; Watson, M.A.; Crouch, E.; Suman, V.J.; Dockter, T.J.; Sanati, S.; Mita, M.; Anurag, M.; Gibbs, R.A.; Rimawi, M.F.; Ellis, M.J.; Leitch, A.M.; Unzeitig, G.W.; Fernandez-Martinez, A.; Fan, C.; Perou, C.M.; Carey, L.A.; Hahn, O.; Guenther, J.M.; Caudle, A.; Hunt, K.K.; Tiersten, A.; Razaq, W.; Hieken, T.J.; Wang, Y.; Weiss, A.; Partridge, A.H.; Winer, E.P.
Source
In: JAMA Oncology . (JAMA Oncology, 21 March 2024, 10(3):362-371)
Subject
Language
English
ISSN
23742445
23742437
23742437